The disruption of Nf in neuronal damage occurring within neurodegenerative conditions results in the release of Nf into the cerebrospinal fluid (CSF), consequently giving rise to elevated NfL concentrations in the CSF and blood, as seen in neurodegenerative diseases (15–17). The gene discussed is NFASC; the disease is neurodegenerative disease.